+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells

Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells

Hypertension 50(6): 1093-1098

Angiotensin (Ang)-(1-7), acting through the Mas receptor, opposes the actions of Ang II. Molecular mechanisms for this are unclear. Here we sought to determine whether Ang-(1-7) influences Ang II signaling in human endothelial cells, focusing specifically on Src homology 2-containing inositol phosphatase 2 (SHP-2) and its interaction with c-Src. Ang II-induced phosphorylation of c-Src, extracellular signal regulated kinase (ERK)1/2, and SHP-2 and activation of NAD(P)H oxidase were assessed in the absence and presence of Ang-(1-7) (10(-6) mol/L, 15 minutes) by immunoblotting and lucigenin-enhanced chemiluminescence, respectively. (D-Ala(7))-Ang I/II (1-7) (Ang fragment 1-7 receptor antagonist) was used to block Ang-(1-7) effects. Association between SHP-2 and c-Src was assessed by immunoprecipitation/immunoblotting studies. Ang II significantly increased activation of c-Src, ERK1/2, and NAD(P)H oxidase and reduced phosphorylation of SHP-2 (P<0.05) in human endothelial cells. These effects were abrogated in cells pre-exposed to Ang-(1-7). Ang fragment 1-7 receptor antagonist pretreatment blocked the negative modulatory actions of Ang-(1-7) on Ang II-induced signaling. Ang-(1-7) alone did not significantly alter phosphorylation of c-Src, ERK1/2, and SHP-2 and had no effect on basal activity of NAD(P)H oxidase. SHP-2 and c-Src were physically associated in the basal state. This association was increased by Ang-(1-7) and blocked by Ang fragment 1-7 receptor antagonist. Our findings demonstrate that, in human endothelial cells, Ang-(1-7) negatively modulates Ang II/Ang II type 1 receptor-activated c-Src and its downstream targets ERK1/2 and NAD(P)H oxidase. We also show that SHP-2-c-Src interaction is enhanced by Ang-(1-7). These phenomena may represent a protective mechanism in the endothelium whereby potentially deleterious effects of Ang II are counterregulated by Ang-(1-7).

(PDF emailed within 0-6 h: $19.90)

Accession: 030084988

Download citation: RISBibTeXText

PMID: 17984366

DOI: 10.1161/HYPERTENSIONAHA.106.084848

Related references

Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling. Journal of Gastrointestinal Surgery 12(1): 57-66, 2007

Angiotensin II induces leukocyte adhesion to human coronary endothelial cells via a non-AT1, non-AT2 angiotensin II receptor. Circulation 94(8 SUPPL ): I41, 1996

Angiotensin-(1-7) treatment ameliorates angiotensin II-induced apoptosis of human umbilical vein endothelial cells. Clinical and Experimental Pharmacology and Physiology 39(12): 1004-1010, 2014

Angiotensin II reduces membranous angiotensin-converting enzyme 2 in pressurized human aortic endothelial cells. Journal of the Renin-Angiotensin-Aldosterone System 10(4): 210-215, 2010

Angiotensin II - induced superoxide anion release is mediated by angiotensin type 1 receptor in human endothelial cells. Journal of Molecular & Cellular Cardiology 29(5): A50, 1997

Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway. International Journal of Molecular Medicine 30(4): 811-818, 2013

Identification of intracellular proteins and signaling pathways in human endothelial cells regulated by angiotensin-(1-7). Journal of Proteomics 130: 129-139, 2016

Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells. Atherosclerosis 212(1): 206-212, 2010

Time-resolved quantitative phosphoproteomics: new insights into Angiotensin-(1-7) signaling networks in human endothelial cells. Journal of Proteome Research 11(6): 3370-3381, 2014

Angiotensin II regulates vascular and endothelial dysfunction: recent topics of Angiotensin II type-1 receptor signaling in the vasculature. Current Vascular Pharmacology 4(1): 67-78, 2006

Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 22(11): 1845-1851, 2002

PI3K/AKT signaling pathway plays a role in enhancement of eNOS activity by recombinant human angiotensin converting enzyme 2 in human umbilical vein endothelial cells. International Journal of Clinical and Experimental Pathology 7(11): 8112-8117, 2015

Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism. Journal of Hypertension 32(11): 2109-19; Discussion 2119, 2016

Angiotensin II-induced fluid phase endocytosis in human cerebromicrovascular endothelial cells is regulated by the inositol-phosphate signaling pathway. Journal of Cellular Physiology 169(3): 455-467, 1996

PI3K/Akt/uncoupling protein 2 signaling pathway may be involved in cell senescence and apoptosis induced by angiotensin II in human vascular endothelial cells. Molecular Biology Reports 41(10): 6931-6937, 2015